文献速递神经肿瘤

海绵窦脑膜瘤的自然史

Natural history of cavernous sinus meningiomas.
PubMed 文献 · J Neurosurg · 2018-03-30

该前瞻性系列纳入53例连续的海绵窦脑膜瘤患者,中位随访10.2年(范围2-25年),从1990年至2016年。83%的肿瘤无显著生长,80%的患者随访结束时无症状,5年、10年和20年影像学无进展生存率分别为90%±4.2%、82%±5.7%和70%±10.2%。作者认为症状性药物治疗高度有效,这些病变在自然、临床和影像学上呈惰性。

要点

  • 53例海绵窦脑膜瘤中83%无显著生长,80%随访结束时无症状。
  • 5年、10年、20年影像学无进展生存率分别为90%±4.2%、82%±5.7%、70%±10.2%。
  • 28例主要症状患者中19例(67.9%)经症状性药物治疗后无症状。

核心结论

  • 由于海绵窦脑膜瘤生长多变、不可预测且缓慢,且患者间生长变异性高,症状性药物治疗是高度有效的方法。
  • 本系列显示这些病变在自然、临床和影像学上呈惰性。

研究设计与样本

  • 前瞻性系列研究,纳入53例连续的海绵窦脑膜瘤患者,中位随访10.2年(范围2-25年),时间跨度为1990年至2016年。

主要发现

  • 患者年龄30至72岁(平均53岁)。
  • 28例患者以主要症状(主要为动眼神经麻痹和神经痛)诊断,15例以次要症状(头痛、间歇性复视)诊断,10例为偶然发现。
  • 短期皮质类固醇和卡马西平的症状性治疗使28例主要症状患者中19例(67.9%)变为无症状,使15例初始次要症状患者中12例(80%)变为无症状(p < 0.0001)。
  • 所有偶然发现的患者保持无症状。
  • 53例海绵窦脑膜瘤中44例(83%)无显著生长,53例患者中42例(80%)随访结束时无症状(p < 0.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Meningiomas confined to the cavernous sinus (MCSs) are benign tumors. Due to the high risk of severe complications, the intracavernous surgical procedure was abandoned in favor of radiotherapy. However, the choice of treatment remains complicated due to the fact that the natural history of this lesion has not yet been described. METHODS: The authors studied the natural history of this lesion using a prospective series of 53 consecutive patients suffering from MCSs. The median follow-up duration was 10.2 years (range 2-25 years), from 1990 to 2016. RESULTS: Patients ranged in age from 30 to 72 years (mean 53 years). The meningiomas were diagnosed by major symptoms (mainly oculomotor palsy and neuralgia experienced in 28 patients), minor symptoms (headache, intermittent diplopia in 15 patients), or incidental findings (10 patients). Simple symptomatic treatment (short courses of corticosteroids and carbamazepine) allowed patients to become asymptomatic in 19 (67.9%) of 28 cases experiencing major symptoms, and for 12 (80%) of 15 patients with initial minor symptoms (p < 0.0001). All patients with incidental findings remained asymptomatic. Forty four (83%) of 53 MCSs did not show any significant growth and 42 (80%) of 53 patients were not symptomatic at the end of follow-up (p < 0.001). The radiographic progression-free survival rates (± SD) at 5, 10, and 20 years were 90% ± 4.2%, 82% ± 5.7%, and 70% ± 10.2%, respectively. Five patients (9.4%) with no evidence of any effect of the initial medical treatment desired additional conventional radiation therapy. CONCLUSIONS: Because of the capricious, unpredictable, and slow growth of MCSs, together with high growth variability from one patient to the next, the symptomatic medical treatment of these tumors is a highly effective method. This series shows that these lesions are naturally, clinically, and radiologically indolent.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Amelot A, van Effenterre R, Kalamarides M, et al. Natural history of cavernous sinus meningiomas. J Neurosurg. 2018. PMID: 29600913. doi:10.3171/2017.7.JNS17662

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。